Home » Stocks » Zafgen

Zafgen, Inc. (ZFGN)

May 29, 2020 - ZFGN merged into LRMR
Stock Price: $0.990 USD 0.000 (0.00%)
Updated May 28, 2020 4:00 PM EDT

Stock Price Chart

Key Info

Market Cap 37.10M
Revenue (ttm) n/a
Net Income (ttm) -35.89M
Shares Out 3.12M
EPS (ttm) -0.96
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day May 28, 2020
Last Price $0.990
Previous Close $0.990
Change ($) 0.000
Change (%) 0.00%
Day's Open 1.020
Day's Range 10.000 - 12.510
Day's Volume 4,323,149
52-Week Range 0.619 - 12.510

More Stats

Market Cap 37.10M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 3.12M
Float 16.52M
EPS (basic) -0.97
EPS (diluted) -0.96
FCF / Share -0.92
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 523,135
Short Ratio 2.48
Short % of Float 1.69%
Beta 0.27
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 0.73
Revenue n/a
Operating Income -35.94M
Net Income -35.89M
Free Cash Flow -34.27M
Net Cash 44.45M
Net Cash / Share 1.19
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -20.65%
ROE -53.93%
ROIC -56.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$9.36*
Low
9.36
Current: $0.990
High
9.36
Target: 9.36
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue--------
Operating Income-45.65-61.12-53.00-58.23-73.81-35.53-13.78-13.79
Net Income-45.41-61.37-52.03-57.88-74.29-36.48-14.03-13.88
Shares Outstanding37.3532.2327.4327.3026.7612.190.730.71
Earnings Per Share-1.22-1.90-1.90-2.12-2.78-3.00-19.53-19.65
Operating Cash Flow-40.78-51.49-43.78-51.98-59.55-28.24-15.00-13.59
Capital Expenditures-1.35-0.11-0.06-0.66-0.60-0.06-0.02-
Free Cash Flow-42.13-51.60-43.84-52.64-60.15-28.30-15.02-13.59
Cash & Equivalents71.6011810212918511535.520.00
Total Debt22.5820.6420.003.596.397.56--
Net Cash / Debt49.0297.4382.0512617910835.520.00
Assets80.7312210613218911838.14-
Liabilities27.1128.4927.299.8920.0013.082.92-
Book Value53.6293.2778.22122169104-68.57-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zafgen, Inc.
Country United States
Employees 7
CEO Jeffrey S. Hatfield

Stock Information

Ticker Symbol ZFGN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ZFGN
IPO Date June 19, 2014

Description

Zafgen, Inc., a clinical-stage biopharmaceutical company, develops methionine aminopeptidase 2 inhibitors for common and rare metabolic disorders. The company was founded in 2005 and is headquartered in Boston, Massachusetts.